HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Schmidt Selected Research

Matrix Metalloproteinases (MMPs)

10/2022The association of six autoimmune bullous diseases with thyroid disorders: a population-based study.
10/2021European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II.
10/2021The burden of neurological comorbidities in six autoimmune bullous diseases: a population-based study.
9/2021European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I.
1/2019A sensitive and specific assay for the serological diagnosis of antilaminin 332 mucous membrane pemphigoid.
1/2018[Mucous membrane pemphigoid].
11/2011[Treatment-refractory anti-laminin 332 mucous membrane pemphigoid. Remission following adjuvant immunoadsorption and rituximab].
1/2011Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid.
4/2008[Mucous membrane pemphigoid with ocular involvement. Part II: therapy].
2/2007Rituximab in autoimmune bullous diseases: mixed responses and adverse effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Schmidt Research Topics

Disease

45Bullous Pemphigoid (Pemphigoid)
11/2022 - 01/2000
25Pemphigus (Pemphigus Vulgaris)
10/2022 - 05/2000
15Blister (Bulla)
04/2021 - 01/2000
9Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa)
10/2022 - 01/2000
8Skin Diseases (Skin Disease)
11/2022 - 01/2001
4Neoplasms (Cancer)
10/2021 - 02/2007
4Autoimmune Diseases (Autoimmune Disease)
04/2014 - 08/2009
3Pemphigoid Gestationis (Herpes Gestationis)
10/2022 - 01/2000
3Psoriasis (Pustulosis Palmaris et Plantaris)
04/2021 - 06/2013
3Blindness (Hysterical Blindness)
11/2011 - 01/2005
3Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis)
05/2010 - 02/2007
3Inflammation (Inflammations)
04/2008 - 05/2000
2Stroke (Strokes)
10/2021 - 09/2013
2Dermatitis Herpetiformis (Disease, Duhring's)
06/2021 - 01/2000
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2018 - 01/2000
2Crohn Disease (Crohn's Disease)
12/2016 - 02/2002
2Multiple Sclerosis
08/2016 - 03/2016
2Glaucoma
02/2009 - 05/2006
2Open-Angle Glaucoma (Glaucoma, Open Angle)
02/2009 - 04/2008
2Epidermolysis Bullosa
03/2004 - 11/2000
2Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid)
11/2001 - 01/2000
2Neurodegenerative Diseases (Neurodegenerative Disease)
10/2001 - 05/2000
1Thyroiditis
10/2022
1Epilepsy (Aura)
10/2021
1Vasculitis (Vasculitides)
02/2018
1Fever (Fevers)
02/2018
1Rheumatic Diseases (Rheumatism)
02/2018
1Myositis (Idiopathic Inflammatory Myopathies)
02/2018
1Disease Progression
01/2018
1Castleman Disease (Castleman's Disease)
01/2017
1Pathologic Complete Response
10/2016
1Parkinson Disease (Parkinson's Disease)
08/2016
1Neuromyelitis Optica (Devic's Disease)
03/2016
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2016
1Pruritus (Itching)
04/2014
1Hiatal Hernia
01/2014

Drug/Important Bio-Agent (IBA)

37AutoantibodiesIBA
11/2022 - 01/2000
16Immunoglobulin G (IgG)IBA
01/2022 - 04/2000
13Proteins (Proteins, Gene)FDA Link
11/2022 - 05/2000
12AntibodiesIBA
01/2019 - 11/2000
11Rituximab (Mabthera)FDA Link
12/2020 - 08/2005
10Matrix Metalloproteinases (MMPs)IBA
10/2022 - 02/2007
8Adrenal Cortex Hormones (Corticosteroids)IBA
12/2021 - 02/2000
6Immunoglobulin A (IgA)IBA
06/2021 - 01/2000
6Laminin (Merosin)IBA
10/2016 - 03/2004
5KalininIBA
10/2021 - 01/2011
5ImmunosorbentsIBA
02/2013 - 02/2007
5EnzymesIBA
02/2013 - 02/2007
5EpitopesIBA
11/2012 - 11/2000
4Collagen Type XVIIIBA
11/2022 - 12/2013
4Immunosuppressive Agents (Immunosuppressants)IBA
04/2019 - 06/2003
4Azathioprine (Imuran)FDA LinkGeneric
04/2019 - 01/2012
4MethylprednisoloneFDA LinkGeneric
11/2017 - 09/2002
4DapsoneFDA Link
11/2017 - 02/2000
4AntigensIBA
12/2013 - 05/2000
4Collagen Type VIIIBA
02/2013 - 09/2002
3Mycophenolic Acid (Cellcept)FDA LinkGeneric
04/2019 - 11/2011
3Prednisolone (Predate)FDA LinkGeneric
10/2018 - 02/2000
3Dexamethasone (Maxidex)FDA LinkGeneric
09/2013 - 11/2011
2DesmogleinsIBA
01/2022 - 01/2001
2SaltsIBA
06/2021 - 01/2011
2Complement System Proteins (Complement)IBA
01/2019 - 01/2001
2Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2019 - 09/2013
2Doxycycline (Periostat)FDA LinkGeneric
10/2018 - 01/2018
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2018 - 11/2011
2Intravenous Immunoglobulins (IVIG)FDA Link
01/2018 - 08/2009
2Ustekinumab (CNTO 1275)FDA Link
12/2016 - 06/2013
2Glycoproteins (Glycoprotein)IBA
09/2013 - 04/2000
2CytokinesIBA
08/2009 - 11/2000
2Interleukin-6 (Interleukin 6)IBA
08/2009 - 11/2000
2Staphylococcal Protein A (Protein A)IBA
11/2006 - 06/2003
2Extracellular Matrix ProteinsIBA
08/2004 - 03/2004
2Fibronectins (Fibronectin)IBA
03/2004 - 02/2002
2polyglutamineIBA
10/2001 - 05/2000
2Interleukin-8 (Interleukin 8)IBA
04/2001 - 11/2000
2AutoantigensIBA
04/2001 - 01/2000
2Indomethacin (Indometacin)FDA LinkGeneric
10/2000 - 05/2000
1Antipsychotic Agents (Antipsychotics)IBA
11/2022
1Hypoglycemic Agents (Hypoglycemics)IBA
11/2022
1DystoninIBA
11/2022
1Immunoglobulin Fc FragmentsIBA
01/2022
1neonatal Fc receptorIBA
01/2022
1Prednisone (Sone)FDA LinkGeneric
12/2021
1Omalizumab (Xolair)FDA Link
07/2021
1Glutens (Glutelin)IBA
06/2021
1Synthetic CathinoneIBA
01/2020
1p38 Mitogen-Activated Protein KinasesIBA
01/2020
1Eosine Yellowish-(YS) (Eosin)IBA
01/2020
1Tinzaparin (Innohep)FDA Link
01/2019
1SteroidsIBA
10/2018
1TetracyclinesIBA
10/2018
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
02/2018
1Imatinib Mesylate (Gleevec)FDA Link
01/2016
1HLA-DRB1 Chains (HLA DRB1)IBA
04/2015
1Biological ProductsIBA
01/2014

Therapy/Procedure

17Therapeutics
01/2022 - 10/2001
2Drug Therapy (Chemotherapy)
09/2008 - 10/2007
1Kidney Transplantation
02/2018
1Off-Label Use
02/2018
1Biological Therapy
02/2018